Book with Confidence
As the world begins to re-open and in-person events become a reality, the 2nd Ligase Targeting Drug Development Summit is committed to bringing you expert insights and industry connections back in a face-to-face capacity. Through liaising closely with the community, we have equipped ourselves with the necessary knowledge to make the right decision to deliver a high-quality event for the industry in a safe capacity, and we hope you and your team will join us for the real event experience!
We are planning on running this as an in-person event in Boston. However, in the result that a high-quality physical event is not able to be delivered, we will revert to our tried and tested virtual platform to deliver the conference in a digital format. Our risk-free booking policy means that you will be covered if the switch to a digital event takes place.
To provide you with certainty, we are committed to ensuring risk-free booking for you and your team. If there are changes in the event, or your own circumstances, we will be able to discuss suitable options with you.
Your health, safety and well-being remains our highest priority. Therefore, all attendees will be required to complete a health declaration prior to attending the event. As part of this, attendees must declare that they are either fully vaccinated and/or have completed a negative Lateral Flow Test or PCR Test within 48 hours before the event.*
For further information around Health and Safety onsite, please visit our FAQ here.
*Please note, this is subject to change at any time without prior notice.